Hulamin Earnings Call Transcripts
Fiscal Year 2025
-
Revenue grew 2% to ZAR 13.1 billion despite operational setbacks and a 2% volume decline, while normalized EBIT fell 77% due to currency and plant issues. Strategic investments are complete, with production and margins expected to improve in 2026.
-
Revenue rose 8% year-over-year, but normalized EBITDA fell 20% due to currency and cost pressures. Strategic exits from non-core divisions and aggressive cost reduction aim to restore margins and reduce gearing below 25% by 2027.
-
The AGM covered board elections, committee appointments, and approval of all resolutions, with most passing by large margins. Shareholders raised concerns about profitability, dividends, and executive alignment, while management outlined ongoing strategic reviews and plans to address these issues.
Fiscal Year 2024
-
Sales volumes rose 2% year-over-year despite operational setbacks, with normalized EBIT down 22%. Strategic investments in wide can body capacity and plant reliability continue, while net debt increased to ZAR 1.3 billion with ZAR 700 million headroom.
-
Local sales surged 77% year-on-year, now 54% of total, offsetting export weakness. Normalized EBIT fell 27% year-on-year, but improved sequentially. Strategic CapEx and recycling initiatives support future growth and margin improvement.